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Role for Fyn and Lyn kinases in the regulation of 
IgG-mediated systemic anaphylaxis 
 
 
 
 
 
  
ABSTRACT 
Lyn but not Fyn kinase controls IgG-Mediated Systemic Anaphylaxis 
By 
Yves Trésor Falanga 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University 
Virginia Commonwealth University, 2012 
 
Director: John J. Ryan, Professor, Department of Biology 
 
Anaphylaxis is a rapid, life-threatening hypersensitivity reaction. Until 
recently, it was mainly attributed to histamine released by mast cells activated by 
allergen crosslinking (XL) of FcεRI-bound allergen-specific IgE. However, recent 
reports established that anaphylaxis could also be triggered by basophil, 
macrophage and neutrophil secretion of platelet activating factor subsequent to 
FcγR stimulation by IgG/Ag complexes. I have investigated the contribution of 
Fyn and Lyn tyrosine kinases to FcγRIIb and FcγRIII signaling in the context of 
IgG-mediated passive systemic anaphylaxis (PSA). I found that mast cell IgG XL 
induced Fyn, Lyn, Akt, Erk, p38 and JNK phosphorylation. Additionally, IgG XL of 
mast cells, basophils and macrophages resulted in Fyn- and Lyn-regulated 
mediator release in vitro. FcγR–mediated activation was enhanced in Lyn-
deficient (KO) cells, but decreased in Fyn KO cells, compared to wild type cells. 
  
xxiii 
More importantly, Lyn KO mice displayed significantly exacerbated PSA features 
while no change was observed for Fyn KO mice, compared to wild type 
littermates. Intriguingly, this work establishes that mast cells account for the 
majority of serum histamine in IgG-induced PSA. Taken together, these findings 
establish pivotal roles for Fyn and Lyn in the regulation of PSA and highlight their 
unsuspected functions in IgG-mediated pathologies.  
 
 
 1 
CHAPTER 1 – INTRODUCTION 
A short history of Immunology (1) 
 Immunology, from its latin origin “immunis” (meaning exempt), is a branch 
of biology and biomedical sciences focused on the immune system.  
 The story of immunology dates back from antiquity. In fact, ancient 
civilizations were based upon strong spiritual and superstitious beliefs in which 
the occurrence of disease or death was solely perceived as a punishment from 
the gods after trespass or sins. These stories are found in religious documents 
and tales such as the mythological story of Pandora box and Pharaoh and the 
Egyptian plague in the Bible. Therefore, these early societies established deities, 
Priests, Shamans, Taboos and sacrifices. The practice of prayers and 
incantations and the wearing of amulets were common ways to be granted 
protection from diseases and death by the gods. 
 Reports of extraordinary and exceptional individuals resistant to plague in 
ancient Greece, or unaffected by dangerous snake venoms in North Africa, or 
surviving severe pandemics have been mentioned in history. Numerous 
historians will agree that the main causes of mortality in ancient civilizations were 
related to infectious diseases and poison. Contrasting with civilizations of their 
times, Greek and Roman philosophers and scientists such as Socrates and 
Galen had a rational approach to the etiology of disease. They postulated that 
disease was coming from imbalance of humors (blood, phlegm, yellow bile and 
black bile) or presence of bad air (mal-aria). In addition to this theory, many 
believed that infectious diseases were caused by poison, generally known from 
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its latin name “virus” (or Pharmakeia in Greek). One of the oldest pandemic 
cases documented is “the plague of Athens”, epidemic that decimated ancient 
Greece around 430 B.C., killing Pericles and about the fourth of the Greek 
population on its way. It was noted that individuals who survived that plague were 
never or at least somewhat less affected by further occurrence of this zoonotic 
disease. One of the fascinating stories comes from ancient Roman Emperor 
Mithridates VI, who decided to inoculate himself with low and increasing doses of 
poison in order to render himself resistant to a potential poisoning by his enemies. 
This later concept, nowadays known as desentization, is clinically used to render 
severely allergic patients tolerant to the allergen that would in normal conditions 
cause critical conditions or fatalities.  
 It is not until the end of the 19th century that the etiology and pathogenesis 
of common infectious diseases were starting to be understood, essentially with 
Louis Pasteur’s revolutionary “germ theory”, which stipulates that infectious 
diseases are caused by germs. Louis Pasteur’s findings are also credited to be at 
the origin of the concept of acquired immunity. At that period of history, the 
Institut Pasteur in Paris was the epicenter of modern bacteriology. For example, 
Pierre-Paul Émile Roux, closest collaborator of Pasteur and co-founder of the 
Institut Pasteur, discovered the anti-diphtheria toxin. At the same time, after 
accepting an invitation from Roux, Alexander Yersin joined the Institute and 
characterized the bacillus responsible for the bubonic plague. This bacillus was 
later named on his honor (Yersinia pestis). Furthermore, DNA studies on remains 
from the victims of the 14th century “Black death” showed that Yersinia pestis was 
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in fact the pathogen that caused the deadliest pandemics in human history.  
 The late 19th century and early 20th century was populated with brilliant 
scientists who contributed to modern microbiology and immunology such as 
Robert Koch and his discovery of Bacillus anthracis, the tuberculosis bacillus and 
vibrio cholerae. During the same period at the Robert Koch Institute in Germany, 
Emil von Behring and Kitasato discovered antibodies to diphtheria and tetanus. 
They uncovered that over the course of diphtheria, the human body was 
producing protective substances (antitoxins) that were circulating in the blood (2, 
3). More important was the evidence that the “so-called” protection could be 
transferred from one individual to another. This discovery saved numerous lives 
and allowed Behring to win the first Nobel Prize for physiology and medicine in 
1901 while Koch received his in 1905 (1). Discoveries from the Koch Institute 
greatly contributed to shape modern microbiology and immunology, with the 
nascent discipline of hematology pioneered by Paul Ehrlich. Paul Ehrlich was the 
first to demonstrate that acquired immunity could be transmitted from the mother 
to the offspring (3, 4). He is credited to be the founding father of histology, 
hematology and chemotherapy in addition to immunology (4). He discovered 
mast cells and brought a cellular explanation to most of the infectious diseases 
that struck during that period of history. Additionally, one of the tremendous 
contributions of Paul Ehrlich was his study on the etiology of syphilis (Treponema 
pallidum) and his theory of a “magic bullet” cure capable of eradicating all 
diseases (chemotherapy). His work on syphilis granted him the Nobel Prize for 
physiology and medicine in 1908. 
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 Modern immunology has come a long way, from spiritual and superstitious 
beliefs to a more rational and scientific approach. Over the years and centuries, 
countless theories were postulated to explain the mechanisms by which people 
were infected at first, and how the infection could spread from one individual to 
another [Seed theory “seminaria” from Fracastoro]. Later, brilliant scientists like 
Pasteur, Koch, Behring, Ehrlich Metchnikoff and Jenner not only hypothesized 
but clearly demonstrated that diseases are caused by germs (bacteria, virus), 
that these germs can be transferred from one infected subject to an uninfected 
one and spread to an entire community, decimating villages, cities and countries. 
The greatest contribution from this era in bio-medical sciences was the 
preliminary but pivotal discovery of the immune system: cellular immunology with 
the identification of mast cells and macrophages and humoral immunology with 
the discovery of antibodies and vaccination. 
 
The Immune System 
 The immune system is a biological structure found in living organisms. 
Composed of numerous members, its primary goal is ensuring protection against 
any type of intrusions. All the cells of the immune system arise from a common 
hematopoietic stem cell (HSC) progenitor present in the bone marrow. During the 
early stages of differentiation, some cells migrate from the bone marrow to the 
thymus. Therefore, the bone marrow and the thymus are considered as the 
primary lymphoid organs, in contrast to secondary lymphoid organs such as the 
spleen and the lymph nodes. The robustness of the immune system is dictated 
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by the distinction between self and non-self molecules. In fact, this step is critical 
for the survival of the organism, usually being a matter of life or death. In 
mammals at least, the most commonly encountered pathogens belong to four 
global categories: bacteria, viruses, fungi and parasites. In order to efficiently 
clear the infectious pathogen, the immune system is temporally and functionally 
subdivided in two segments: the innate immune system and the adaptive 
immune system. The first part of this dissertation will focus on cells of the innate 
immune system, specifically mast cells, basophils and macrophages whereas the 
second part will cover mechanisms of the adaptive immune system and the study 
of B cells. 
• The innate immune system 
 The innate immune system is the first line of defense against pathogenic 
infections. While the cellular compartment of the innate immune system is 
composed of circulating (monocytes, basophils, neutrophils and eosinophils) and 
resident cells (macrophages and mast cells), the humoral section is mainly made 
out of complement molecules. Once differentiated from the bone marrow’s 
common myeloid progenitor (CMP), some cells of the innate immune system will 
always circulate in the blood stream (monocytes, basophils, neutrophils and 
eosinophils) while others such as mast cells and macrophages will migrate to the 
tissue. Tissue-resident cells generally locate at the vicinity of the external 
environment: under the skin, in the airway and in intestinal epithelia for example. 
In fact, upon recognition of pathogen associated molecular patterns by 
specialized receptors such as those of the Toll-like receptor family (TLR) present 
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on the cell surface or through immunoglobulin receptors, cells from the innate 
immune system secrete chemicals (cytokines, chemokines, and lipid-derived 
mediators) that will induce the death of the pathogen and the recruitment of other 
immune cells.  
 
•  The Adaptive immune system 
 During the initial phase of infection, specialized antigen-presenting cells 
(APCs) like dendritic cells (DCs) will process the antigens associated with the 
pathogen, migrate to the closest secondary lymphoid organ and trigger 
mechanisms of the adaptive immune response by presenting the processed 
antigen to an antigen-specific T cell. Activated T cells will then activate antigen-
specific B cells, which will later undergo isotype switch and somatic 
hypermutation (SHM) and differentiate into antibody-producing plasma cells. 
Plasma cells secrete a variety of antibodies, all recognizing the antigen with 
different affinity. During the process of isotype switching, plasma cells produce 
different classes of antibodies (isotype), ranging from IgM, IgD, IgG, IgE to IgA. 
Antibody molecules are constituted of two parts: the antigen-binding fragment 
(Fab), recognizing the antigen and the Fc fragment responsible for the effector 
function by binding to Fc receptors (Figure 1). For example, the high affinity IgE 
receptor FcεRI present on mast cells will bind to the Fc portion of IgE molecules 
while FcγRIII expressed by macrophages will bind to IgG molecules. 
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Regulation of the Immune system via the Fc receptors 
 As mentioned earlier, some cells of the immune system express Fc 
receptors and have the capability to recognize Fc portions of antibodies. In fact, 
ligation of antigen-bound antibodies to the receptor will trigger an intracellular 
cascade of events culminating in calcium mobilization, transcription factor 
activation and the release of mediators. These mechanisms are subject to fine 
regulation by the cellular machinery. Subsequently, any defects in the control of 
cell activation will generally result in pathological conditions such as allergies, 
asthma and systemic anaphylaxis. While the initiation of an allergic response is 
commonly attributed to mast cell activation via FcεRI (5, 6), scientists agree that 
it is the combination of many different factors that lead to the onset of this 
condition. Furthermore, in some cases, the exposure to IgE-bound allergen 
causes rapid and exacerbated hypersensitivity reactions called anaphylaxis.  
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Figure 1 
Immunoglobulin structure.  
Immunoglobulins or antibodies are proteins made up of two light chains (red) and 
two heavy chains (blue). Each chain contains both the variable region 
(responsible of antigen recognition) and the constant region. The two heavy 
chains are linked to each other and to the light chain by disulfide bonds. 
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Consequently, the role of mast cells in allergy, inflammatory diseases and 
immune homeostasis has been most extensively studied downstream of IgE 
receptor signaling (7-13), although interesting studies reported that mast cells 
can also be activated by their IgG receptor (14) (Figure 2). Data generated from 
murine models demonstrate that an anaphylactic reaction can be induced 
through the IgG-FcγR pathway (15-18). In this “alternative” pathway of 
anaphylaxis, FcγR activation of basophils, macrophages, and neutrophils elicits 
anaphylaxis symptoms, including a drop in core body temperature. 
 
Lyn kinase 
FcεRI activation involves a plethora of signaling molecules, including Fyn 
and Lyn kinases. Lyn kinase, which is expressed as 53 and 56 kDa isoforms due 
to alternative splicing (19-21), is expressed in nearly all immune cells, except the 
T cell lineage. For example, the association of Lyn kinase with the B cell antigen 
receptor (BCR) (22) and the high affinity IgE receptor, FcεRI (23), places Lyn in a 
critical position to control inflammation. Because of the known stimulatory roles 
for Src family kinases, it was assumed that Lyn possessed pro-stimulatory roles 
in signaling. Consistent with this, Lyn knockout (KO) mast cells were found to 
have poor calcium flux responses after IgE-mediated activation (24). However, 
further study – not accounting for the increased IgE in Lyn KO –  showed that 
Lyn deficiency exacerbated IgE-mediated mast cell activation and anaphylaxis 
(25). These apparently contradictory data were explained by the ability of Lyn to 
recruit several inhibitory proteins, including SHIP-1, SHP-2, DOK-1, and CBP 
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(26-29). These negative regulators reduce signaling through other Src family 
members, including PI-3 kinase and the Ras-MAPK cascade. Hence, Lyn 
appears to be a negative regulator of the mast cell response. 
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Figure 2 
Mast cells in innate and adaptive immunity. Mast cells are generally located 
underneath the epithelial membranes such as the skin, the gastrointestinal track 
and the upper respiratory ways. They express the high affinity IgE receptor FcεRI, 
capable of recognizing the Fc portion of IgE molecules. IgE-bound antigen 
aggregation is required for FcεRI activation. Upon FcεRI activation, mast cells 
undergo a rapid release of preformed mediators such as histamine and 
leukotrienes , two potent vasoactive mediators causing vasodilation and smooth 
muscle cell contraction. In the lungs, they are responsible for bronchial 
constriction, generally associated with asthma. Vasodilation in the site of 
infection is critical to the clearance of the pathogen because it facilitates the 
recruitment of other specialized immune cells from the blood vessels to the site 
of infection. Following the immediate degranulation phase, mast cells will secrete 
chemokines and cytokines (even though some of them can be preformed and 
released during the early phase). This second wave of mediators takes longer, 
due to de novo biosynthesis of molecules in response to stimuli. In fact, mast 
cells secrete a plethora of pro- and anti-inflammatory cytokines both promoting 
and inhibiting mast cell activation respectively. For example, mast cell-secreted 
IL-4 and eotaxin triggers mucus production and eosinophil recruitment in the 
lungs, while it induces T cell production of IL-4 and IL-5. These latter cytokines 
are necessary to maintain B cell survival and isotype switch to IgG1 and IgE 
antibodies and important for eosinophils recruitment respectively. Furthermore, 
mast cell activation can lead to the production of anti-inflammatory molecules 
 13 
such as IL-10 and TGF-β acting locally by decreasing the surface expression of 
FcεRI and affecting other immune cells in paracrine mechanisms of action. 
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Fyn kinase 
Fyn on the other hand is a 59 kDa Src-family protein tyrosine kinase 
involved in mast cell degranulation and cytokine release (30, 31). Once 
phosphorylated, Fyn activates the adaptor protein Gab2, initiating the 
phosphatidylinositol-3’ kinase (PI3K) pathway. This enhances calcium flux 
through a TRPC1-mediated process leading to cortical F-actin depolymerization 
(32). In addition, Fyn enhances transcription factor activity, degranulation and 
cytokine release (6, 25). Fyn activation is currently viewed as a positive regulator 
of IgE-mediated inflammatory signals, similar to the well-documented Syk kinase 
pathway. 
 
Regulation of the immune response by FcγRs 
In addition to FcεRI, mast cells express the IgG receptor family (FcγR). 
The high-affinity IgG receptors include FcγRI in humans and mice, and FcγRIV in 
mice only, while the low affinity IgG receptors include FcγRII and FcγRIII, in 
humans and mice. Humans have three FcγRII (A, B, and C) and two FcγRIII (A 
and B) whereas mice have one receptor of each type (FcγRIIB and FcγRIIIA) 
(33). Activating FcγR on mouse cells consist of a ligand-binding alpha-chain (α) 
and a signal-transducing gamma-chain (γ) bearing immunoreceptor tyrosine-
based activation motif (ITAMs), which once phosphorylated upon receptor 
crosslinking, act as a docking site for signaling molecules such as Syk kinase, 
resulting in the initiation of activatory signaling pathways. In contrast, ligand 
binding can also result in downregulation of antigen-dependent mediator release 
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due to the existence of the immunoreceptor tyrosine-based inhibitory motif 
(ITIMs) on the cytosolic portion of FcγRIIB α-chain. Subsequent phosphorylation 
of ITIM upon FcγRIIB ligation induces the activation of Lyn kinase, which will 
recruit and activate phosphatases like SHIP in addition to directly activating ITIM, 
leading to decreased mediator release (34). FcγRIIB inhibits several aspects of 
mast cell and basophil functions such as IgE-dependent degranulation and IL-4 
production (35, 36). Additionally, beside mast cells, FcγRIIB is also expressed by 
other immune cells including dendritic cells, macrophages, activated neutrophils, 
basophils and B cells. When expressed by these cells, FcγRIIB inhibits the 
functions of activating FcγRs, such as phagocytosis and pro-inflammatory 
cytokine release (33, 35, 36). 
 
Similarities between IgE and IgG receptors 
 IgG receptors (FcγR) share a common gamma subunit with FcεRI (Figure 
3), and share similar signaling pathways. Although the importance of Syk kinase 
in IgG signaling has been demonstrated (37, 38) little is known about Src family 
kinase functions. A major part of this study will focus on understanding the 
importance of Fyn and Lyn kinases in FcγR signaling in mast cells, basophils, 
and macrophages as well as the involvement of these two kinases in patho-
physiological events such as anaphylaxis. 
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Figure 3 
Similarities between FcεRI and the Fcγ receptors family.  
The high affinity IgE receptor FcεRI is constitutively expressed on mast cells and 
basophils surface while in some conditions, monomeric IgE can trigger its 
expression on eosinophils and human macrophages. FcεRI is constituted of one 
alpha chain, one beta chain and two gamma chains linked by disulfide bonds. 
IgE and IgG molecules have similar structures, as do their receptors. In fact, the 
IgG receptor family comprises activating receptors bearing intracellular ITAMs 
(FcγRI, FcγRIII and FcγRIV in mice, and FcγRI, FcγRIIA, FcγRIIC and FcγRIIIA 
in humans) and inhibitory receptors with intracellular ITIMs (FcγRIIB) in mice and 
humans. Activating IgG receptors have similar structures, related to FcεRI. They 
are formed of an alpha chain and two gamma chains while the inhibitory FcγRIIB 
is constituted by a unique alpha chain. In addition to triggering cell activation and 
inhibition, these receptors are also involved in phagocytosis and anaphylaxis. 
They are expressed on macrophage, DC, mast cell, neutrophil and eosinophil. 
They bind to specific subclasses of IgG molecules with different specificities. 
Malfunction or deficiency in these receptors is linked to recurrent bacterial and 
parasitic infections and autoimmune diseases. [Cell types in bold font represent 
the cell population that has the highest expression level]. 
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When things go wrong 
In pathologic and particular conditions, mast cell activation with antigen-
specific IgE can lead to anaphylaxis, a rapid and life-threatening hypersensitivity 
reaction. The onset and regulation of anaphylaxis has been exclusively attributed 
to mast cells, delineating the classical pathway of anaphylaxis involving IgE-
mediated FcεRI mast cell activation and subsequent histamine release (5). 
However, elegantly conducted research on murine models demonstrates that an 
anaphylactic reaction can be induced through the IgG-FcγR pathway (15-18). In 
this novel pathway of anaphylaxis, activation of basophils and macrophages 
(FcγRI and FcγRIII) (15-17), and recently FcγRIV on neutrophils (18) elicits 
anaphylaxis signs, including a drop in core body temperature. Additionally, mast 
cells have recently been reported to be responsible for FcγRIIA-dependent 
cutaneous anaphylaxis whereas monocyte/macrophages and neutrophils were 
found to be involved in FcγRIIA-dependent systemic anaphylaxis (39).  
Our findings show that Fyn, Lyn, Akt, Erk, p38 and JNK are activated upon 
FcγR stimulation, and that Fyn and Lyn regulate FcγR-mediated degranulation, 
cytokine and chemokine release not only in mast cells, but also basophils and 
macrophages. Furthermore, we demonstrate that mast cells account for the 
majority of circulating histamine during FcγR-induced passive systemic 
anaphylaxis (PSA), which is regulated by Fyn and Lyn. Moreover, we show that 
Lyn, but not Fyn kinase, is a major regulator of IgG-mediated PSA. These results 
bring new insights to the function of Fyn and Lyn kinases downstream of FcγR 
stimulation.  
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CHAPTER 2 – DISSERTATION OBJECTIVE 
 Numerous studies have demonstrated the importance of Src family 
kinases in the regulation of the immune response. As mentioned earlier, Juan 
Rivera’s group was able to demonstrate that Fyn and Lyn kinases have 
antagonistic functions in mouse mast cell IgE receptor stimulation. Fyn -/- mast 
cells showed decreased mediator release while Lyn -/- cells displayed an 
exacerbation. These findings led us to consider the following hypotheses:  
• Primarily, we wanted to know whether these two kinases were activated 
upon IgG receptor stimulation. If they are, what are their functions in mast 
cells? This hypothesis is of significant relevance given that IgG molecules 
are the most abundant Ig in the serum and that mast cells express three 
isoforms of the IgG receptor (FcγRI, FcγRIIB and FcγRIII). 
• Additionally, like mast cells, basophils and macrophages also express 
FcγRI, FcγRIIB and FcγRIII. We consequently wanted to test the 
hypothesis that Fyn and Lyn kinases have regulatory roles in IgG-
mediated cell activation in these cells. 
• The regulation of the immune system includes a diversity of cell lineages 
and a plethora of molecules. We therefore sought to investigate the 
regulatory roles of Fyn and Lyn kinases in the context of IgG-mediated 
passive systemic anaphylaxis, using a mouse model. 
• The second part of this dissertation focuses on investigating the role of 
Fyn kinase in antibody production. While IL-4 is a vital cytokine for B cell 
survival and isotype switching, recent studies reported that Fyn kinase is 
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required for T cell IL-4 production. Consequently, we wanted to test the 
hypothesis that Fyn kinase has a role in antibody production. 
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CHAPTER 3 – MATERIAL AND METHODS 
Animals 
C57BL/6x129sv wild type (WT), C57BL/6x129sv Fyn-deficient (KO), 129sv WT 
and 129sv Lyn KO inbred strains were described previously (25, 30). Mast cell-
deficient Wsh-/- and their C57Bl/6 control mice were purchased from the Jackson 
Laboratory. All mice were used at a minimum of 9 weeks of age, and all 
experiments received approval from the Virginia Commonwealth University 
institutional animal care and use committee (IACUC). 
 
Cytokines and reagents 
Cytokines and ELISA assay kits were purchased from PeproTech (Rocky Hill, 
NJ). Bio-plex Pro cytokine assay kits were purchased from BioRad (Hercules, 
CA). Histamine and leukotriene C4 (LTC4) ELISA kits were purchased from 
Cayman Chemicals (Ann Arbor, MI) and Neogen Corporation (Lansing, MI). 
Cytokine measurements were performed as per the manufacturer’s directions. 
Antibodies specific for tyrosine-phosphorylated (pY) Lyn and total Lyn were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies specific 
for the tyrosine-phosphorylated form of the Src kinase activation loop (pY416), 
phospho Erk (p44/p42 MAPK Thr 202/Tyr 204), Erk, phospho Akt (Thr 308), Akt, 
phospho p38, p38, phospho JNK (Thr 183/Tyr 185), JNK and for Fyn were 
purchased from Cell Signaling Technologies (Danvers, MA). Anti-mouse 
FcεRIα was purchased from eBioscience (San Diego, CA). Rat anti-mouse 
FcRγII/RIII (2.4G2) were a kind donation of Professor Fred Finkelman from 
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Cincinnati Children Hospital (Cincinnati, OH). Purified mouse IgE, rat anti-mouse 
IgE, rat IgG isotype control, and rat IgG anti-c-kit (CD117) were purchased from 
BD Pharmingen (San Diego, CA).  
 
Cells 
Mouse bone marrow-derived mast cells (BMMCs) were derived by culture in 
complete RPMI (cRPMI) 1640 medium (Invitrogen Life Technologies, Carlsbad, 
CA) containing 10% heat-inactivated FBS, 2 mM L-glutamine, 100 U/ml penicillin, 
100 mg/ml streptomycin, 1mM sodium pyruvate, and 1 mM HEPES (all from 
Biofluids, Rockville, MD), supplemented with IL-3–containing supernatant from 
WEHI-3 cells and stem cell factor (SCF)-containing supernatant from BHK-MKL 
cells. The final concentration of IL-3 and SCF was adjusted to 1 ng/ml and 10 
ng/ml, respectively, as measured by ELISA. Mouse bone marrow-derived 
basophils were obtained by culturing bone marrow cells for six days in cRPMI 
1640 medium supplemented with 5 ng/ml recombinant IL-3 (PeproTech, Rocky 
Hill, NJ). At day 6, they were analyzed and sorted by flow cytometry on the basis 
of FcεRI-positive and Kit-negative characteristics. Mouse bone marrow-derived 
macrophages were obtained by culturing bone marrow cells for eight days in 
cRPMI supplemented with 50 ng/ml MCSF (PeproTech).  
In vitro activation of antibody production 
Naïve B cells were isolated using magnetic beads following manufacture’s 
protocol (Miltenyi Biotec). Briefly, single cell suspension was generated and cells 
were resuspended in MACS buffer (PBS pH 7.2, 0.5% BSA and 2mM EDTA) and 
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incubated with anti-CD43 magnetic beads for 15 minutes at 4°C. Cells were then 
washed and passed through a magnetic column. Flow-through was collected. For 
IgG1 and IgE production, B cells were cultured with 1µg/mL of stimulating anti-
CD40 antibody (Invitrogen) and IL-4 (10,000U/mL) for seven days. Supernatants 
were then harvested and analyzed for IgG1 and IgE production by ELISA. For 
western blots, B cells were stimulated with 30ng of IL-4 (Peprotech). 
 
Quantification of antibody titers by ELISA 
For total IgM and IgG1 ELISAs, samples were serially diluted and added to 96-
well plates (50µL/well) pre-coated with 5 µg/mL of goat-anti IgM and IgG, 
respectively (Southern Biotech). For standard curve, normal mouse IgM and 
IgG1 (Southern Biotech) were used. After incubation at 37°C for 1 h, bound Abs 
were revealed by goat-anti-IgM-AP and goat-anti-IgG1-AP, respectively 
(Southern Biotech). Total IgE ELISA was carried out as previously described 
[34,35]. For antigen-specific ELISAs, ELISA was carried out as described with 
minor modifications [34]. Plates were coated with NP14BSA (Biosearch 
Technologies)(15 µg/mL in PBS) for samples and with 5 µg/mL of goat-anti Ig 
(Southern Biotech) in PBS for standard. Standard curves were performed by 
coating with anti- IgM, anti-IgG1, anti-IgG2a or IgG2b and adding known 
amounts of IgM, IgG1, IgG2a or IgG2b, respectively. The values for experimental 
samples are reflected as relative units (RU) because serum antigen-specific Abs 
were captured with antigen. The remaining steps were carried out as described. 
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Proliferation 
To determine proliferation, cells were isolated and stimulated as described (see 
above). After 96 hours in culture, cells were pulsed with 1 µCi/well of tritiated 
([3H])-thymidine (Perkin Elmer) for 24 hrs. Plates were then harvested onto GFC 
plates using a filtermate cell harvester. Plates were dried for at least 2 hours, 
25µL of scintillation fluid was added, and counts were determined using the 
Topcount Plate Counter (Perkin Elmer, Waltham, MA). Proliferation was reported 
as counts per minute (CPM). 
 
Flow cytometry 
Mice were bled via tail vein nick and spleens were isolated. Cells were labeled 
following RBC lysis and filtration through 40µm cell strainers. Antibodies included 
unlabeled CD16/32 (2.4G2), FITC-conjugated anti-mouse c-Kit (2B8) and Gr-1 
(RB6-6B2); PE-conjugated anti-FcεRIα (MAR-1) and Gr-1 (RB6-8C5); Alexa 647- 
conjugated anti-mouse CD49b (DX5) and B220 (RA3-6B2); PE-Cy7 conjugated 
anti-mouse CD3 (145-2C11) and CD11b (M1/70) from BioLegend; and PE-
conjugated anti-Siglec-F (E50-2440) from BD Biosciences. Flow cytometric 
analysis was performed using a Canto (BD Biosciences) and data analysis was 
conducted with FlowJo software (Tree Star). B cell isolation and labeling was 
conducted as described previously [34,36]. Cells were labeled following RBC 
lysis and filtration through 40 µm cell strainers. Abs included anti-mouse 
unlabeled 2.4G2, biotinylated CXCR5 (RF8B2); PE-conjugated Fas (Jo2); APC-
conjugated GL7 (GL7), PE-Cy7 conjugated-streptavidin from BD Bioscience; 
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FITC-conjugated B220 (RA3-6B2), CD4 (RM4-5) and PerCP-Cy5.5 conjugated 
PD-1 (29F.1A12) from Biolegend. Lymphocytes were gated based on FSC vs. 
SSC. Cell subsets were defined as follows: Plasma cells: B220lo/-CD138+ [36]; 
germinal center B cells: B220+GL7+Fashi [37] and follicular helper T cells: 
CD4+CXCR5+PD-1hi [38] Flow cytometric analysis was performed using a Canto 
or AriaII (BD Biosciences), and data analysis was conducted with FlowJo (Tree 
Star). 
 
 
Western blot 
Cells were dissociated in RIPA (Radio-Immunoprecipitation Assay) buffer and 
Western blotting was performed using 50 µg total cell lysate per sample. Proteins 
were loaded and separated over an 8–16% or 4–20% gradient SDS-
polyacrylamide gel (Bio-Rad, Hercules, CA). Proteins were transferred to 
nitrocellulose membranes (Pall Corporation, Ann Arbor, MI), and blocked for 60 
minutes in Blotto B buffer (Rockland Immunochemicals, Gilbertsville, PA) plus 
0.1% Tween-20. Blots were incubated in a solution of TBS supplemented with 
0.1% Tween-20 and 5% BSA (TBST), with the indicated antibodies overnight at 
4°C with gentle rocking. Blots were washed six times for 10 minutes each in 
TBST, followed by incubation in Blotto B containing a 1:5,000 dilution of HRP 
linked anti-IgG matched to the relevant species, from Cell Signaling (Danvers, 
MA). Size estimates for proteins were obtained using molecular weight standards 
from Bio-Rad (Hercules, CA). 
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Microscopy 
Cells were sensitized with 10 µg/ml of 2.4G2 for 60 minutes at 4ºC and washed 
3x with phosphate buffered saline (PBS). Alexa Fluor 488-conjugated goat anti-
rat IgG (Jackson ImmunoResearch, West Grove, PA) was added to the cell 
suspension at the concentration of 10 µg/ml and the cells were incubated at 37ºC 
5% CO2. At appropriate time points, 5 x 104 cells were centrifuged at 1500 g for 
5 min at 4°C. The cells were then cytocentrifuged onto glass slides at 1000 g for 
3 min in a Cytospin 4 centrifuge (Thermo Electron, Pittsburgh, PA) and fixed in 
methanol for 4 min. Slides were stained for immunofluorescence microscopy as 
previously described (40). Primary antibodies were Fyn and Lyn (Santa Cruz 
Biotechnologies, Santa Cruz, CA), both at dilutions of 1:50, followed by 
Rhodamine Red (Jackson ImmunoResearch, West Grove, PA), at a dilution of 
1:50. Slides were mounted with the Prolong gold antifade reagent with DAPI 
(Invitrogen). Images were acquired by spinning disc confocal microscopy using a 
BX51 microscope (Olympus, Center Valley, PA) affixed with an Olympus disk 
spinning unit and an Ocra-R2 CCD camera (Hammamatsu, Japan). Images were 
processed using the Slidebook software package (Intelligent Imaging Innovations, 
Denver, CO). 
 
Passive Systemic Anaphylaxis 
Mice were injected intravenously with 200 µl of PBS containing 5mg of histamine, 
700 ng of PAF or 500 µg of rat anti-mouse CD16/CD32, clone 2.4G2 (17, 41). 
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The core body temperature of each animal was measured using a rectal 
microprobe (Physitemp Instruments). Mice were then euthanized, and blood was 
collected by cardiac puncture to prepare serum.  
 
Lungs inflation 
Two hours after the induction of PSA, mice were sacrificed and lungs were 
inflated with Agarose (Invitrogen) pre-warmed at 60ºC, administered through 
intra-tracheal incision. Animals with inflated lungs were then directly placed on 
ice. Later the lungs were resected from the animal and stored into 40 ml of 10 % 
Neutral Buffered formalin. Lung sections, mounts and Hematoxylin-Eosin (H&E) 
staining were performed by the Virginia Commonwealth University’s Department 
of Pathology (Richmond, VA). Lung sections were imaged with a Nikon E-600 
compound microscope using a 20× objective. 
 
PAF acetyl hydrolase (AH) Activity Assays  
Substrate (50µM 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine with 0.05 µCi of 
hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine, 1-O-[acetyl-(N)-3H] 
(NEN/PerkinElmer; 13.5 Ci/mmol) added as a tracer), was combined with Serum 
and incubated for 30 minutes at 37º C to determine PAFAH enzymatic activity. 
PAFAH activity was expressed as release of [3H] acetate, using a method that 
we described previously (42). 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine 
(PAF) was purchased from Avanti Polar Lipids (Alabaster, AL).  
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Statistical Analysis 
Data are presented as the mean plus or minus SEM of at least 3 independent 
experiments. Comparisons were made by the two-tailed Student t test for 
independent samples. P values less than 0.05 were considered statistically 
significant. Analysis was performed with GraphPad Prism software. 
  
 29 
CHAPTER 4 – RESULTS 
 
Regulation of IgG receptor signaling by Fyn and Lyn kinases 
 
• FcγR stimulation induces rapid Fyn, Lyn, Akt, Erk, p38 and JNK activation 
in bone marrow-derived mast cells. 
We first observed that only Lyn kinase deficiency affected mast cell 
surface expression of FcγRIIB and FcγRIII (2.4G2 staining) (Figure 4). 
Furthermore, Lyn kinase deficiency appeared to have a dominant phenotype in 
Fyn/Lyn double KO mast cells. In order to compare the effect of IgE versus IgG 
receptor stimulation on the phosphorylation state of Fyn kinase, bone marrow-
derived mast cells were stimulated in vitro with IgE plus antigen or 2.4G2 plus 
anti-IgG (referred to as IgE or 2.4G2 crosslinking (XL) respectively). Fyn kinase 
was then immunoprecipitated and proteins separated by SDS-PAGE. The 
phosphorylated form of Fyn was detected by immunoblotting for the activation 
loop of the Src kinase family on residue 416 (pY416) (Figure 5a). Our results 
show that Fyn kinase (59kDa) is rapidly activated downstream of both the IgE 
and the IgG receptors. Quantification of western blot signal intensity by 
densitometry after adjusting for loading showed that FcεR and FcγRI activate Fyn 
to a similar extent. 
Comparable to Fyn, we found that both Lyn kinase isoforms (53 and 56 kD) (21) 
were also activated following 2.4G2 XL (Figure 5b). FcγR-mediated Lyn 
activation was nearly as strong as IgE-mediated effects as attested by 
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densitometry analysis of band intensity. Furthermore, staining of Fyn or Lyn by 
immunofluorescence after 2.4G2 XL in BMMC revealed a diffuse cytoplasmic 
location of these two kinases, not only at the proximity of FcγRIIB and FcγRIII 
(Figures 5c, 5d and Figure 6) 
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Figure 4 
Lyn deficiency affects FcγRII/RIII surface expression on mast cells.  
Bone marrow-derived mast cells were cultured in IL-3 and SCF as described in 
the material and methods section. Surface expression of FcγRII/RIII 
(CD32/CD16) levels were assessed with a fluorescently labeled rat IgG2b 
molecule (2.4G2 clone) recognizing both FcγRII/RIII (CD32/CD16). The graph 
summarizes 3 independent experiments. Data shown are mean ± SEM. 
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Figure 5 
Fyn and Lyn kinases are activated upon FcγRIIB/RIII stimulation of bone 
marrow-derived mast cells. BMMCs were sensitized with either anti-DNP IgE 
(10 µg/ml) or rat anti-mouse FcγRII/III 2.4G2 (10 µg/ml) and stimulated with DNP-
HSA (100ng/ml) (IgE XL) or goat anti-rat IgG (10 µg/ml) (2.4G2 XL) respectively 
for the indicated times. (a) Fyn immunoprecipitation and western blotting with 
anti-Src kinase activation loop antibody (pY416). Total Fyn expression is shown 
as a loading control. The image is representative of 3 independent experiments. 
Data shown are mean ± SEM. The fold induction was quantified by densitometry 
analysis of band intensity with Image J software. The mean fold change is 
relative to the control cells receiving media alone as stimulus. (b) Western blot 
for activated Lyn, detected with anti-phosphotyrosyl 396 Lyn antibody. Total Lyn 
expression represents the loading control. The image is representative of 3 
independent experiments. (c, d) BMMCs were sensitized with 10 µg/ml of 2.4G2 
for 60 minutes at 4ºC and cross-linked with 10 µg/ml of Alexa Fluor 488-
conjugated goat anti-rat IgG [Green] for indicated time-points before being 
cytocentrifuged onto glass slides for microscopy analysis (Refer to the material 
and methods section). Fyn and Lyn are visualized by rhodamine X-conjugated 
secondary antibodies [Red] recognizing anti-Fyn and anti-Lyn primary antibodies. 
Cell nuclei are visualized by DAPI staining [Blue]. Images were acquired by 
spinning disc confocal microscopy using a BX51 microscope (Olympus, Center 
Valley, PA) affixed with an Olympus disk spinning unit and an Ocra-R2 CCD 
camera (Hammamatsu, Japan). Images were processed using the Slidebook 
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software package (Intelligent Imaging Innovations, Denver, CO). Representative 
images of at least 3 independent experiments. 
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Figure 6 
Immunofluorescence strategy for the dynamic study of Fyn, Lyn, FcγRIIB 
and FcγRIII   
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Intracellular signaling events occurring in mast cells after FcεRI activation 
of have been intensively studied and are well established. Since our results show 
that comparable activation levels of Fyn and Lyn can be achieved through FcεR 
or FcγRI stimulation, we next decided to investigate the dynamics of 
phosphorylation events subsequent to Fyn and Lyn activation. We found that Fyn 
activation after 2.4G2 crosslinking occurred rapidly, with maximal 
phosphorylation observed within 3 minutes (Figure 7a). In addition, FcγR 
activation of mast cells triggered the activation of Akt, Erk, p38 and JNK (Figure 
7b). A representative densitometry analysis of band intensity shows the 
phosphorylation dynamics of these signaling molecules (Figure 7c), with ERK 
phosphorylation being the strongest, reaching about 70-fold increase in less than 
a minute after the initiation of 2.4G2 XL. Our results showed parallel 
phosphorylation for Fyn, Akt and Erk during the early time points of FcγR 
activation of mast cells, with only Lyn displaying sustained phosphorylation over 
about 30 minutes. Collectively, our results show that comparable Fyn and Lyn 
activation can be achieved through FcεR or FcγRI stimulation. In addition, FcγR-
mediated signals activated similar downstream targets to those previously shown 
for FcεRI signaling (30, 43-49), especially the robust and early Akt and Erk 
signaling. 
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Figure 7 
FcγR stimulation activates Fyn, Lyn, Akt, Erk, p38 and JNK in BMMCs. 
BMMCs were sensitized with rat anti-mouse FcγRII/III 2.4G2 (10 µg/ml) and 
stimulated with goat anti-rat IgG (10 µg/ml) (2.4G2 XL) respectively for the 
indicated times. (a) Fyn was immunoprecipitated and activated Fyn was detected 
by an anti-Src kinase activation loop antibody (pY416) after 2.4G2 XL. Total Fyn 
expression is shown as a loading control. (b) Representative immunoblot of the 
phosphorylation kinetics of Lyn, Akt, Erk, p38 and JNK after 2.4G2 XL. Total 
protein expression is shown as loading control. (c) Phosphorylation time course 
of activated Lyn (pY396), Akt (pT308), Erk (pT202/pY204), p38 (pT180/pT182) 
and JNK (pT183/pY185) upon 2.4G2 XL. The densitometry analysis of band 
intensity was calculated using the Image J software. Fold change is relative to 
the control cells incubated in media alone. The graph summarizes 3 independent 
experiments. Data shown are mean ± SEM. 
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• Effects of Fyn or Lyn deficiency downstream of mast cell IgG receptor 
signaling  
Fyn and Lyn kinases act as opposite regulators of IgE-induced mast cell 
activation (25), (30, 31). We therefore investigated their roles in IgG-mediated 
BMMC activation. In order to fairly compare how downstream signaling 
molecules are affected by Fyn or Lyn deficiency, we depleted these kinases with 
specific siRNA on C57BL6 mast cells, given that Fyn KO and Lyn KO were 
generated on different backgrounds (B6.129sv and 129sv, respectively). Fyn KO 
BMMCs displayed increased phospho-JNK while no change was observed for 
phospho-Akt and phospho-p38 subsequent to IgG XL (Figure 8a, 8b). On the 
other hand, Lyn-deficient BMMCs displayed significantly high phospho-Akt while 
there was no change in JNK or p38 phosphorylation status in comparison to WT 
BMMCs. Complementing the data in Figure 6, these data demonstrate that Fyn 
and Lyn regulate particular signaling pathways upon IgG XL in mast cells by 
targeting different downstream signaling molecules.  
 
• Fyn kinase deficiency diminishes FcγR-mediated activation of mast cells, 
basophils, and macrophages 
To determine the functional importance of Fyn kinase downstream of 
FcγR signaling, BMMCs derived from WT or Fyn KO bone marrow progenitors 
were stimulated by 2.4G2 crosslinking, and cell culture supernatants were 
collected to measure degranulation and cytokine release. Fyn deficiency 
significantly decreased histamine release (Figure 9a), and profoundly reduced IL-
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6 (Figure 9b) and IL-13 (Figure 9c) levels. There were no striking differences in 
leukotriene C4 (LTC4), MIP-1 alpha or TNF-alpha secretion (data not shown).  
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Figure 8 
Effects of Fyn or Lyn deficiency on mast cell FcγR stimulation.  
Fyn or Lyn kinases were knocked down by siRNA in BMMCs, which were then 
stimulated with 2.4G2 XL for the indicated times. (a) Representative image of Lyn, 
Fyn, phospho-Akt, phospho-JNK, phospho-p38 immunoblot after SDS-page 
western blot. Total Fyn, Lyn, Akt (pT308), JNK (pT183/pY185), p38 
(pT180/pT182) and GAPDH lanes are shown as loading controls. (b) 
Phosphorylation kinetics of activated Akt, p38 and JNK upon 2.4G2 XL. The 
densitometry analysis of band intensity was calculated using Image J software. 
Fold change is relative to the control cells incubated in media alone.  
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We used the calcium ionophore ionomycin as a positive control for all of 
our cytokine and mediator release measurements in this study and observed that 
the deficiency in either Fyn or Lyn did not significantly impact the amount of 
mediators secreted (data not shown). These data mirror previous reports of the 
importance for Fyn kinase in IgE-mediated stimulation (25, 30), expanding its 
significance to FcγR stimulation. 
Basophils and macrophages share FcγRIIB/III expression with mast cells, 
and are also involved in innate immunity. In macrophages, FcγRs receptors 
regulate a variety of functions, such as macrophage activation or inhibition as 
well as opsonization of antibody-neutralized pathogens (50-54). Recent studies 
have identified the pivotal importance of basophils and macrophages in IgG-
related allergic and anaphylactic reactions (17, 55-61). To determine the 
functional relevance of Fyn kinase downstream of FcγR signaling in basophils 
and macrophages, these cells were derived from WT and Fyn KO bone marrow 
as described in Materials and Methods. Interestingly, after 2.4G2 crosslinking, we 
observed that Fyn KO basophils and macrophages displayed a significant 
decrease in secreted cytokines and chemokines in comparison to the WT 
cultures (Figures 9d-h). These data demonstrate that Fyn kinase is required for 
optimal FcγR-mediated activation basophils and macrophages in addition to mast 
cells. 
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Figure 9 
Fyn kinase deficiency diminishes mast cell, basophil and macrophage 
FcγR-mediated activation. 
(a, b, c) WT and Fyn KO BMMC were activated with 2.4G2 XL as described in 
Figure 5 for 1 hour to measure early phase mediators (Histamine) or 18 hours for 
cytokine release, analyzed by ELISA. (d, e) WT and Fyn KO bone marrow-
derived macrophages were activated for 18 hours , and cell supernatant was 
analyzed by ELISA. (f, g, h) WT and Fyn KO bone marrow-derived basophils 
were activated for 18 hours and cell supernatant analyzed by ELISA. Data shown 
are mean ± SEM of at least 3 independent experiments done in triplicate. 
*p<0.05; **p<0.001; ***p<0.0001 based on Student’s t test Fyn WT to Fyn KO 
cells. 
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• Lyn kinase deficiency enhances FcγR-mediated activation of mast cells, 
basophils and macrophages 
To determine the role of Lyn in FcγR signaling, wild type and Lyn KO mast 
cells were stimulated by 2.4G2 crosslinking. We found that Lyn KO BMMCs 
displayed a significant increase in the secretion of early phase mediators such as 
Leukotriene C4 (LTC4) (Figure 10a). Additionally, the amount of IL-13 and MIP-
1α released was significantly increased in Lyn KO BMMCs compared to the 
control cells (Figures 10b, 10c). However, we did not observe a significant 
increase in histamine and other cytokines including TNF-alpha (data not shown). 
These results support the idea that Lyn kinase selectively regulates the amount 
of mediators released upon FcγR stimulation in BMMCs. Similar results were 
observed in macrophages (Figures 10d, 10e) and basophils (Figures 10f-h), 
where Lyn deficiency also selectively enhanced FcγR-mediated 
cytokine/chemokine release. Taken together, our findings support that Fyn and 
Lyn kinases are key opposing regulators of FcγR-dependent mast cell, basophil 
and macrophage activation.  
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Figure 10  
Lyn kinase deficiency enhances FcγR-mediated mast cell, basophil, and 
macrophage activation. 
(a, b, c) WT and Lyn KO BMMC were activated with 2.4G2 XL as described in 
Figure 5 for 1 hour to measure early phase mediators (Leukotriene C4) or 18 
hours for cytokine release, and analyzed by ELISA. (d, e) WT and Lyn KO bone 
marrow-derived macrophages were activated for 18 hours, and cell supernatant 
was analyzed by ELISA. (f, h) WT and Lyn KO bone marrow-derived basophils 
were activated for 18 hours as described above, and cell supernatant was 
analyzed by ELISA. Data shown are mean ± SEM of at least 3 independent 
experiments done in triplicate. *p<0.05; **p<0.001; ***p<0.0001 based on 
Student’s t test WT to Lyn KO cells. 
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Regulatory functions of Fyn and Lyn kinases during FcγR-induced passive 
systemic anaphylaxis (PSA) 
• Lyn but not Fyn kinase regulates IgG-induced PSA 
The importance of Fyn and Lyn in FcγR signaling prompted us to 
investigate their regulatory roles in vivo, in the context of passive systemic 
anaphylaxis (PSA). We performed an IgG-mediated PSA assay using 
intravenously injected 2.4G2 (41). Recent studies have reported that mast cells 
are not required for IgG-mediated PSA, and identified basophils, macrophages 
and neutrophils as the key players (15, 17, 18). Both Fyn KO age and gender-
matched littermate mice developed anaphylaxis as assessed by decreased core 
body temperature, followed by a recovery period of approximately 2 hours. Unlike 
in vitro FcγR stimulation (Figure 9), Fyn deficiency did not convey protection from 
anaphylaxis severity (Figure 11a).  
In contrast, 2.4G2-induced PSA was exacerbated in Lyn KO mice 
compared to their wild type littermates (Figure 11b), correlating with our in vitro 
observations with mast cells, basophils and macrophages (observed in Figure 
10). Despite a dramatic (11°C) drop in body temperature, none of the Lyn KO 
mice died in this experiment. Furthermore, the comparison of Fyn KO and Lyn 
KO mice lungs two hours after PSA did not reveal any drastic changes in airway 
inflammation features such as perivascular edema or immune cell infiltration 
(Figure 11c). Surprisingly, we noticed that Lyn kinase deficiency not only 
exacerbated the severity of IgG-induced PSA but also, significantly extended the 
recovery time after the onset of anaphylaxis (the data will be discussed later in 
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this dissertation). Additionally, we did not observe any changes in circulating 
cytokines (Bioplex for GM-CSF, IL-1β, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17α, MCP-
1, MIP-1α, MIP-1β and TNF) in the sera of mice 2 hours after 2.4G2-induced 
PSA (Figure 12). In general, 129Sv mice (Lyn WT and KO) displayed a lower 
nadir than their Fyn WT and KO counterparts. This could be due to higher 
numbers of blood basophils, monocytes and neutrophils on this genetic 
background. Furthermore, we noticed that Fyn KO mice had significantly low 
monocyte numbers compared to their WT littermates. This observation only 
partly contributes to understanding the observed phenotype. Also, we found that 
Fyn or Lyn deficiency did not affect circulating B cell, T cell or eosinophil 
percentages (Figure 13). 
 
• Fyn and Lyn kinases regulate serum histamine during PSA 
Histamine and platelet-activating factor (PAF) are very potent mediators causing 
bronchoconstriction, vascular leak and vasodilation, three features observed 
during human and mouse systemic anaphylaxis (17, 41, 59, 62, 63). Due to a 
paucity of sensitive assays for measuring PAF, and given that both PAF and 
histamine cause anaphylaxis, we next investigated the effects of 2.4G2-induced 
PSA on circulating histamine levels in the context of Fyn or Lyn deficiency. Our 
results showed that the serum of Fyn KO mice contained significantly lower 
histamine levels than their wild type counterparts (Figure 14a). In contrast, Lyn 
KO mice displayed elevated serum histamine compared to their littermates, in 
agreement with their exacerbated PSA phenotype (Figure 14b).  
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Figure 11 
Lyn but not Fyn kinase deficiency is pivotal to IgG-induced passive 
systemic anaphylaxis. 
(a,b) PSA was induced with intravenous injection of 500µg of 2.4G2. Changes in 
the core body temperature were measured by rectal micro-probe [Fyn WT (PBS, 
n=4; 2.4G2, n=6), Fyn KO (PBS, n=3; 2.4G2, n=5), Lyn WT (PBS, n=3; 2.4G2, 
n=3), Lyn KO (PBS, n=3; 2.4G2, n=4)]. (c) Two hours after the induction of PSA, 
mice were sacrificed and their lungs were inflated with Agarose (in 10 % 
formalin) pre-warmed at 60ºC, later placed on ice and stored into 40 ml of 10% 
Neutral Buffered formalin. Hematoxylin-Eosin (H&E) staining on lung sections 
was imaged with a Nikon E-600 compound microscope using a 20× objective. 
The black arrows indicate perivascular edema. Data shown represent the mean ± 
SE.  
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Figure 12 
Serum levels of circulating cytokines and chemokines following IgG-
induced passive systemic anaphylaxis 
PSA was induced with intravenous injection of 500µg of 2.4G2. Two hours later, 
blood was collected by cardiac puncture and serum level of circulating mediators 
was assessed by micro-beads Bioplex Assay. Fyn WT (PBS, n=4; 2.4G2, n=6), 
Fyn KO (PBS, n=3; 2.4G2, n=5), Lyn WT (PBS, n=3; 2.4G2, n=3), Lyn KO (PBS, 
n=3; 2.4G2, n=4). Data shown represent the mean ± SE.  
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Figure 13 
Effects of Fyn and Lyn deficiency on peripheral blood mononuclear cells  
(a,b) Blood from Fyn KO and Lyn KO mice as well as their littermate controls (n = 
8 per group) was collected and the peripheral blood mononuclear cells (PBMCs) 
numbers were assessed by flow cytometry analysis. B cells (CD19+), T cells 
(CD4+), monocytes (CD11b+Gr1–), neutrophils (CD11b+Gr1+), basophils 
(IgE+CD49b+), eosinophils (Gr1+SiglecF+), and mast cells (IgE+CD117+). (c, d, 
e) Comparison of basophils, monocytes and neutrophils percentages between 
Fyn KO and Lyn KO mice as well as their littermates control. Data shown 
represent the mean ± SE.  
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• Mast cells account for the amount of serum histamine released in IgG-
induced PSA 
 Mast cells and basophils degranulate and release histamine once 
activated through their FcγR. Our results show that the amount of histamine 
released in the serum during IgG-induced PSA is regulated in a Fyn and Lyn 
dependent-manner (Figures 14a, 14b). However, the cell population accounting 
for the amount of released histamine remained unclear. To address this question, 
we induced PSA by 2.4G2 intravenous injection into wild type or mast cell-
deficient mice (Wsh-/-) mice, and monitored the drop in core body temperature. 
As seen in Figure 15a, Wsh-/- mice developed PSA to a similar extent as their 
WT controls (C57BL6). Surprisingly, mast cell-deficient mice had little serum 
histamine two hours after the induction of PSA in comparison to their controls 
(Figure 15b). Our data demonstrate that mast cells account for the majority of 
histamine released during IgG-induced PSA.  
 
• Lyn kinase deficiency induces increased vascular sensibility to histamine 
In vivo vascular sensibility to histamine depends on the amount of 
histamine administered, the number of functionally available histamine receptors 
and the contribution of signaling molecules downstream of the histamine 
receptor. In order to assess the impact of Fyn and Lyn kinase deficiency in the 
vascular sensitivity to histamine, we intravenously injected 5 mg of histamine into 
Fyn KO, Lyn KO and their wild type counterparts (Figure 14c). While Fyn KO 
mice exhibited anaphylactic responses mirroring their littermates, Lyn KO mice 
 58 
were more responsive than controls when given the same amount of histamine, 
suggesting that Lyn deficiency might also affect the vasculature in addition to 
regulating the amount of released histamine.  
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Figure 14 
Fyn and Lyn kinases regulate the amount of serum histamine during IgG-
induced PSA 
(a, b) Circulating histamine levels 2 hours after PSA induction [Fyn WT (PBS, 
n=4; 2.4G2, n=6), Fyn KO (PBS, n=3; 2.4G2, n=5), Lyn WT (PBS, n=3; 2.4G2, 
n=3), Lyn KO (PBS, n=3; 2.4G2, n=4)]. Data shown represent the mean ± SE. (c) 
Fyn KO (n=4) and Lyn KO (n=4) mice or control littermates (Fyn, n=4; Lyn, n=4) 
were injected i.v. with 5 mg of histamine and core body temperature was 
measured by rectal microprobe. Data shown represent the mean ± SEM.  
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Figure 15 
Mast cells account for the majority of serum histamine released during IgG-
induced PSA 
(a) PSA was induced in mast cell-deficient mice (Wsh-/-, n=4) as well as their WT 
controls (C57BL6, n=5) by intravenous injection of 500µg of 2.4G2. The core 
body temperature was monitored by rectal microprobe. Data shown are the mean 
± SEM. Two hours after the induction of PSA in (a), blood was collected from 
mice, serum prepared and the amount of circulating histamine was assessed by 
ELISA (b). Data shown are the mean ± SE.  
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PAF injection recapitulates IgG-mediated PSA in Fyn and Lyn KO mice while the 
deficiency in neither Fyn nor Lyn affects PAF acytylhydrolase (PAFAH).  
PAF is known to be the main mediator regulating IgG-induced PSA (15-
18). To assess its importance in our model, we intravenously injected PAF 
(700ng) into Fyn KO, Lyn KO, and matched wild type mice (Figure 16a). PAF 
administration recapitulated IgG-mediated PSA kinetics in Fyn and Lyn KO 
(Figures 11a, 11b). Since PAF is the key factor in IgG-mediated anaphylaxis, we 
assessed serum activity levels of its inactivating enzyme, PAF acetylhydrolase 
(PAFAH). As shown in Figure 16b, steady-state PAFAH serum enzymatic activity 
was unaffected by Lyn or Fyn deficiency. Furthermore, we observed that Lyn 
deficiency not only worsened anaphylaxis severity (Figures 11b, 14c, 16a), but 
also lengthened the recovery time to approximately 5 hours, instead of the 2 
hours observed with littermate controls (Figure 17). These findings could be 
explained by increased leakage from endothelial cells, or altered decay rates for 
these anaphylactic mediators. Collectively, these data suggest that Lyn 
deficiency exacerbates responses to both histamine and PAF. Paired with 
enhanced macrophage and basophil responsiveness to IgG, the loss absence of 
Lyn kinase appears to exaggerate the severity and recovery time of anaphylaxis.  
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Figure 16 
Intravenous administration of PAF recapitulates IgG-induced PSA kinetics 
while the deficiency in neither Fyn nor Lyn affects PAF acetylhydrolase 
(PAFAH) 
(a) PSA was induced by intravenous delivery of 700 ng PAF in Fyn KO (n=3) and 
Lyn KO (n=4) as well as their littermate controls (Fyn, n=4; Lyn, n=4). Core body 
temperature was measured by rectal microprobe. Data shown represent the 
mean ± SE. (b) Enzymatic activity of serum levels of PAF acetylhydrolase 
(PAFAH) in Fyn and Lyn KO mice and their control littermates (n≥ 9 per group). 
Data shown represent the mean ± SEM.  
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Figure 17 
Lyn KO mice have exacerbated anaphylaxis and extended recovery time 
Anaphylaxis was induced in Lyn KO mice (n = 4 per treatment groups) by 
intravenous injection of either 5 mg of histamine, 700 ng of PAF or 0.5 mg of 
2.4G2. The severity of anaphylaxis was assessed by core body temperature 
measurements using a rectal microprobe. Mice were monitored over 5 hours until 
recovery. Data shown represent the mean ± SEM.  
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Figure 18 
Roles of Fyn and Lyn kinase in the regulation of Fcγ receptors in mice. 
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Figure 29 
Fyn and Lyn kinases are activated in both the IgE and IgG receptor 
pathways. FcεRI and FcγRIIB/RIII activation by antigen-bound IgE and IgG 
respectively elicit intracellular activation of Fyn and Lyn kinases. Phosphorylation 
of Fyn will lead to the activation of Syk, which will later dock to LAT and trigger 
the activation of the Ras/MAPK, PKC, AP-1 and NFAT pathways. In addition of 
being a positive regulator of receptor signaling, Lyn kinase activation can also 
lead to Csk recruitment through the SH2 domains of Cbp/PAG. Csk is a 
phosphatase which once activated removes phosphate residues from its target 
(such as Fyn kinase), resulting in signal inhibition. In addition, recent data 
suggest that Fyn kinase activation is required for STAT5 transcription factor 
phosphorylation and translocation to the nucleus (64), expanding our 
understanding of the role of this kinase. Receptor activation generally leads to a 
mixture of positive (activating) and negative (inhibiting) signals and 
corresponding mediators. For example, mast cell activation triggers the release 
of a plethora of mediators including IL-10 and TGF-β, two anti-inflammatory 
cytokines. These cytokines can act in an autocrine manner and dampens further 
release of mediators. One plausible hypothesis is that these cytokines trigger the 
synthesis of specific micro-RNAs that will target Fyn and STAT5. 
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CHAPTER 5 – DISCUSSION  
Recently, the Src family kinases Lyn and Fyn have been found to exert 
opposing effects on IgE-mediated mast cell activation (25, 30, 65), but little is 
known about the role of these enzymes in IgG signals. Our findings show that 
FcγR triggers Fyn and Lyn kinase activation similar to FcεRI crosslinkage in mast 
cells (Figures 5, 7), which might be explained by the fact that these two receptor 
families share the common γ chain (33). Furthermore, Fyn and Lyn appear 
important for the regulation of IgG-induced degranulation and cytokine 
production, suggesting an important role in mast cell functions. Here we show 
that Lyn deficiency significantly increases Akt phosphorylation subsequent to 
mast cell IgG receptor stimulation. These data mirror previous observations of 
FcεRI-mediated mast cell activation from Kitaura et al. (43). In that report, IgE XL 
of Lyn KO mast cells induced increased Akt phosphorylation, correlating with 
enhanced NF-κB, NF-AT and AP-1 transcriptional activation and subsequently 
elevated IL-2 and TNF production. Taken together, these data demonstrate that 
Lyn and Fyn kinase play important and similar roles in FcεRI and FcγRIII 
activation of mast cells. The fact that Fyn and Lyn deficiency similarly altered 
FcγR signaling in basophils and macrophages (Figures 9, 10) supports the 
importance of these antagonistically-paired Src-family kinases in IgG-mediated 
immune responses. 
The onset and the regulation of anaphylaxis has been exclusively 
attributed to mast cells, delineating the generally accepted classical pathway of 
anaphylaxis involving IgE-mediated FcεRI mast cell activation and subsequent 
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histamine release (5). In addition to this well-characterized pathway, recent 
reports in the literature demonstrate that in a murine model, the anaphylactic 
reaction can be triggered by an IgG-FcγR pathway. Basophils, macrophages and 
recently neutrophils (18) – but not mast cells – have been identified as crucial 
players in this “alternative pathway of anaphylaxis”, since mast cell-deficient mice 
demonstrated IgG-induced anaphylaxis. In contrast, in vivo depletion of basophils 
with the monoclonal antibody Ba103 (16, 17), or inhibiting macrophage function 
via gadolinium injection (15) markedly decreased the severity of FcγRIII-
mediated anaphylaxis. A recent report further showed that FcγRIV-neutrophil-
induced anaphylaxis also occurs, as mice deficient in 
FcγRI/FcγRIIB/FcγRIIIA/FcεRI/FcεRII–/– (5KO mice) still developed IgG-
mediated anaphylaxis (18). In this alternative form of anaphylaxis, platelet-
activating factor (PAF), rather than histamine, has been indicated as a pivotal 
mediator. While PAF serum levels are quite challenging to measure, the in vivo 
administration of a PAF antagonist protected mice from developing IgG- but not 
IgE-mediated anaphylaxis (17). Thus it is thought that IgG-induced anaphylaxis 
operates through FcγR–mediated activation of basophils, neutrophils and 
macrophages, with subsequent PAF release triggering vasodilation, vascular 
fluid leak, and loss of core body temperature (15, 17, 18, 58). 
Our data support and extend the understanding of IgG-mediated 
anaphylaxis at the molecular signaling level. First, we found that Fyn or Lyn 
deletion has opposing effects on histamine release and cytokine secretion during 
IgG activation of mast cells, basophils, and macrophages in vitro. Interestingly, 
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although the effects on histamine release were consistent in vivo, they did not 
predict the severity of FcγR-induced PSA. While Lyn KO mice showed increased 
histamine and worsened hypothermia, Fyn KO had diminished histamine but no 
change in hypothermia versus respective WT mice. Additionally, although 
histamine and PAF are responsible for anaphylaxis, we found that mast cells 
were mainly responsible for the amount of circulating histamine present in the 
serum during the course of FcγR-induced PSA (Figure 15), extending the 
involvement of mast cells in IgG-related pathologies. It is interesting to note that 
a recent study found histamine produced by non-mast cell sources in a model of 
contact hypersensitivity (66), suggesting that in vivo histamine production varies 
with the eliciting stimulus. Based on previous reports (15-18), the drop in body 
temperature observed in mast cell-deficient animals over the course of 
anaphylaxis should be attributed to PAF released by basophils, macrophages 
and neutrophils after FcγRIII activation. Furthermore, we did not observe any 
significant difference in perivascular cell infiltration and pulmonary edema 
between Fyn KO, Lyn KO and their controls subsequent to 2.4G2-induced PSA 
(data not shown).  
The exacerbated response of Lyn KO mice could be ascribed to many 
factors: increased PAF production (and/or secretion), decreased PAF 
metabolism, or enhanced PAF signaling in vascular endothelium. We found no 
changes in PAFAH activity, suggesting that reduced PAF catabolism is not an 
explanation. Furthermore, we found no overt changes in circulating basophils, 
monocyte, or neutrophils in Lyn KO mice. It is also possible that Lyn KO 
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endothelial cells, just like mast cells, basophils and macrophages, are hyper-
responsive to any stimuli involving Lyn kinase. In fact, Kuruvilla et al. have 
demonstrated that Fyn and Lyn are phosphorylated upon PAF receptor 
activation, leading to phosphorylation of the p85 regulatory subunit of PI3K (67). 
In addition, Yu et al. showed that phospho-tyrosine activated Lyn kinase co-
localized with PI3K in the lipid body fraction of PMN leukocytes subsequent to 
PAF receptor stimulation (68). Taken together, and in line with our findings, we 
therefore speculate that Lyn KO endothelial cells are hyper-responsive to PAF 
stimulation, triggering a longer and more severe vasodilation episode in 
comparison to Lyn-sufficient cells.  
Based on these data, we can hypothesize that patients with altered Lyn 
function or expression could be hyperresponsive to IgE- and IgG-mediated 
pathology. There is precedence for this, as the majority of systemic lupus 
erythematosus (SLE) patients have been shown to have reduced Lyn expression 
in two clinical studies (69, 70). While SLE is regarded as an IgG immune 
complex-mediated disease, Charles et al. recently showed that basophils 
activated by IgE may participate in the onset or the exacerbation of lupus-like 
symptoms in a mouse model (71). In the same report, this group demonstrated 
that aged Lyn KO mice displayed increased basophil numbers in the lymph 
nodes, blood and spleen. Furthermore, Lyn KO mice display significantly 
elevated circulating autoantibodies which, in conjunction with many other factors, 
lead to the development of SLE-like symptoms and contribute to the elevated 
mortality in this population (72-74). Combined with our data, Lyn deficiency is 
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postulated to worsen either IgG- or IgE-mediated inflammation, which could 
contribute to the development of SLE in aged mice.  
Several studies have reported the presence of allergen-specific IgG in 
allergic individuals. The involvement of this immunoglobulin isotype in the onset 
and the development of the allergic reaction remain poorly understood (75, 76). 
However, Bandukwala et al. used a murine model to demonstrate the importance 
of FcγRI and FcγRIII in airway inflammation and hyperresponsiveness. This 
study showed that C57BL/6 mice that were sensitized with noninfectious parasitic 
Schistosoma mansoni eggs and challenged with soluble egg antigen displayed 
airway inflammation, including eosinophil infiltration and severe peribronchial and 
perivascular inflammation. This response was greatly decreased in FcγRI-/- or 
FcγRIII-/- mice (77). This group also demonstrated that deficiency of FcγRIII, but 
not FcγRI, reduced lung resistance upon methacholine challenge, compared to 
littermate controls. Thus, in addition to the well-established role of IgE-FcεRI in 
the onset and the development of allergy and hypersensitivity, this study provides 
evidence that FcγRIII activation can participate in airway disease pathogenesis in 
a murine model. Combined with our data, these findings support the theory that 
the exacerbated 2.4G2-mediated PSA we noted in Lyn KO mice is elicited by 
FcγRIII, as previously supported by Ravetch et al. as well as Daeron et al. (78-
81). 
 The high affinity (FcγRI) and low affinity (FcγRIII) IgG receptors are known 
to be important in the activation of numerous cell types of the immune system 
and in the phagocytosis of opsonized microbes. In contrast, one of the members 
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of the FcγR family, FcγRIIB, has emerged as an inhibitory receptor (41, 82, 83). 
Using a mouse model of allergic asthma, Dharajiya et al. demonstrated that in 
addition to upregulating the expression of FcγRIIB in CD14+MHCII+ mononuclear 
as well as in CD11b+ cells in the lungs, ragweed extract (RWE) challenge also 
led to signs of severe allergic asthma-like symptoms in FcγRIIB-deficient mice, 
delineated by increased airway eosinophilia, mucin production and allergen-
specific IgE. Furthermore, a tremendous increase in macrophage, eosinophil and 
lymphocyte recruitment was observed in the broncho-alveolar lavage fluid of 
RWE-challenged FcγRIIB KO mice in comparison to wild type controls (84). 
These data, as well as many others, consolidate the idea that IgG and Fcγ 
receptors play important roles in the regulation of immune system homeostasis. 
Our data support the hypothesis that Fyn and Lyn kinases are pivotal 
antagonistic regulators of this paired IgG receptor system. 
The data presented demonstrate that Fyn and Lyn kinases are activated 
during IgG-mediated signaling and have opposing regulatory functions in mast 
cells, basophils and macrophages. In addition to Fyn and Lyn activation, I found 
that FcγR stimulation also led to the phosphorylation of Akt, Erk, p38 and JNK. 
Further, I also uncover the contribution of mast cells as major producers of serum 
histamine during IgG-induced PSA, regulated in a Fyn- and Lyn-dependent 
manner. More importantly, the data show that overall Lyn but not Fyn kinase 
regulates the severity of IgG-induced passive systemic anaphylaxis, by 
enhancing the amount of vasoactive mediators secreted and exacerbating 
endothelial cell responsiveness to PAF and histamine. In line with previous 
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studies, these findings extend the understanding of IgG-related pathologies and 
demonstrate the pivotal role of Lyn kinase as the key regulator of IgG-mediated 
inflammation.  
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PART II 
 
 
Fyn kinase is required for optimal antibody 
production 
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ABSTRACT 
The generation of antigen-specific antibodies and the development of 
immunological memory require collaboration between B and T cells. T cell-
secreted IL-4 is important for B cell survival, isotype switching to IgG1 and IgE, 
affinity maturation and the development of germinal centers (GC). Fyn-deficient 
(KO) T cells have reduced IL-4 production after anti-CD3/anti-CD28 stimulation. I 
observed that naïve Fyn KO animals had significantly low basal serum titers of 
IgG1 and IgG2a but not IgG2b and IgM. Further, the data show that Fyn KO mice 
fail to develop robust humoral immunity following a T-dependent antigen 
immunization (NP-KLH), as significantly low titers of NP-specific IgG2a were 
observed in the serum up to 28 days post-immunization. These results correlated 
with significantly low numbers of germinal center (GC) B cells, Follicular Helper T 
cells (TFH) and spleen plasma cells. Interestingly, Fyn kinase deficiency did not 
affect activation-induced cytidine deaminase (AID) nor B cell proliferation when 
cultured with anti-CD40 and IL-4. Furthermore, Fyn KO B cells displayed 
significantly impaired STAT3 and STAT5 activation upon IL-4 stimulation. Taken 
together, these data suggest that Fyn kinase has a role in the development of 
humoral immunity, affecting both B cells and T cells. 
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CHAPTER 1 – INTRODUCTION 
The development of immunological memory is a key hallmark of humoral 
responses. Germinal centers (GCs) are critical for humoral immunity. Within GC, 
B cells undergo class switch recombination (CSR) and somatic hypermutation 
(SHM) – both of these processes are mediated by activation induced cytosine 
deaminase (AID). CSR and SHM lead to the development of plasma cells that 
secrete high affinity, class switched antibodies. GC formation is dependent on 
the interactions between antigen-specific B cells, T cells and follicular dendritic 
cells (FDCs). Antigen-activated B cells upregulate the chemokine receptor CCR7 
expression and migrate toward the T cell zone, while some activated T cells 
upregulate CXCR5 and migrate toward the B cell follicles. It is within the B-T 
border that Follicular helper T cells (TFH) interact with activated B cells presenting 
cognate antigen. This interaction is stable and can last for several minutes. 
During this interaction, TFH cells provide B cell help via CD40L and cytokines, 
such as IL-21 and IL-4. Both of these cytokines are important for germinal center 
formation. Even prior to the discovery of TFH cells, it was demonstrated that 
optimal germinal centers did not form in IL-4Rα or IL-4 deficient mice. IL-4 
signaling is not only required for germinal center formation, but also for class 
switch recombination and somatic hypermutation.  
 
Src family tyrosine kinases (SFKs) are involved in diverse regulatory 
mechanisms of B and T cell homeostasis (85-92). Fyn kinase (59 kDa) for 
example, is known to have critical roles in proximal T cell receptor (TCR) 
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activation (86). It is well documented that in the absence of TFH, GCs fail to 
develop (93-96). Therefore, understanding the factors that regulate TFH 
development has been of great interest. Recent studies demonstrated that 
SLAM-associated protein (SAP) is essential for TFH development, germinal 
center formation and the generation of memory B cells (97-101). In fact, SAP 
recruits Fyn kinase to SLAM by direct binding “via an unconventional SH3 
domain binding surface” that requires arginine residue 78 on the backside of SAP 
SH2 domain (102-104). This recruitment and activation of Fyn is known to be 
essential for CD4 T cell differentiation to Th2 cells (105, 106), NKT cell 
development (107, 108) and controlling IFN-gamma production (102, 105). SLAM 
deficient mice have normal GC formation following viral infection (98). 
Experiments also showed that mutating arginine 78 in SAP-protein impairs SAP-
Fyn interaction without affecting TFH development, suggesting that SAP mediates 
TFH development independently of Fyn (99, 100). These experiments however, 
do not address Fyn’s potential role in TFH development and GC formation, 
independently of SAP signaling. Experiments with Fyn-deficient mice showed 
that they form GCs, although how GC B cell numbers compare to that of wild 
type cannot be deduced from these studies, since Fyn-deficient mice are in a 
B6.129 background and no B6.129 wild type mice were used in that experiment. 
I observed that Fyn KO mice have significantly low basal IgG1 and IgG2a. 
Furthermore, following a T-dependent immunization protocol (Figure 20), these 
mice displayed delayed Ag-specific IgG1 and significantly low Ag-specific IgG2a, 
correlating with significantly reduced numbers of germinal center B cells, 
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Follicular Helper T cells (TFH) and spleen plasma cells. Surprisingly, Fyn-deficient 
B cells did not show significantly decreased AID expression and antibody 
production following in vitro activation with IL-4 and anti-CD40. Taken together, 
these results thus demonstrate that Fyn-mediated signaling is necessary for 
optimal humoral responses in a T-dependent immunization protocol. 
 84 
  
 85 
Figure 20 
Background and research strategy.  
[A] In addition to the B cell receptor (BCR) expression, naive B cells express 
surface IgM. Upon BCR ligation, activated B cells express CD40 and migrate 
toward the T cell zone. Once in the T cell zone, they will interact with activated T 
cells previously primed by a dendritic cell (DC). Follicular Helper T cells (TFH) 
have increased Bcl-6, SAP, iCOS and the chemokine receptor CXCR5, markers 
required for their activation and migration toward the B cell zone. Once antigen-
specific B cells and T cells are in contact, B cells proliferate, form germinal 
centers (GC), undergo class switch recombination and somatic hypermutation. 
[B] Basal antibody titers will be assessed for WT and Fyn KO mice prior to their 
immunization, 7 and 14 days post-immunization (p.i.). Additionally, spleens will 
be extracted to assess T cell, B cell and plasma cell numbers. 
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CHAPTER 2 – RESULTS 
 
Fyn deficient animals have low basal IgG1 and IgG2a 
 Basal circulating antibodies against a given antigen may reflect the 
readiness for the immune system in neutralizing that antigen (and indirectly the 
infectious agent bearing that antigen) during the infection. Therefore, in order to 
better understand Fyn’s role in humoral immunity, we analyzed antibody levels in 
the serum of naïve Fyn-deficient and wild type B6.129 mice. Compared to wild 
type, Fyn-deficient mice had normal IgM levels and IgG2b, but had significantly 
decreased basal IgG1 levels and IgG2a (Figure 21). IgE levels were below the 
levels of detection (results not shown). These findings suggest that, in addition to 
the well-documented functions of Fyn in innate immunity (6, 25, 30, 31, 109), this 
kinase has a role in adaptive immunity through the regulation of antibody 
production. 
 
Fyn kinase deficiency affects antigen-specific IgG1 and IgG2a production 
 In order to directly assess the role of Fyn kinase in antigen-specific 
antibody production, Fyn-deficient mice and their wild type littermates were 
immunized i.p. with 4-Hydroxy-3-nitrophenylacetyl coupled to keyhole limpet 
hemocyanin (NP-KLH) in alum. Serum NP-specific antibody levels were 
assessed at days 7, 14, 21 and 28 post-immunization (Figure 22, Figure 23). In 
line with the previous observations of basal IgM, I did not observe any significant 
difference in NP-specific IgM levels between WT and Fyn KO mice (Figure 22a). 
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Interestingly, Fyn KO mice were able to produce similar levels of NP-IgG1 
compared to their WT control, suggesting that the low IgG1 titers observed in 
naïve mice can be compensated over the course of the immunization protocol 
(Figure 22b). Furthermore, I observed that Fyn KO mice drastically failed to 
produce NP-IgG2a while a slightly delayed trend was noted on the production of 
IgG2b (Figures 22c, 22d). Surprisingly, I did not observe any difference in spleen 
weight between Fyn KO and WT 14 days after the immunization (Figure 24). 
These data support the idea that Fyn kinase plays a role in antibody production, 
affecting selective sub-classes of immunoglobulins. 
 
Germinal center formation, Splenic Plasma cell differentiation and Follicular 
Helper T cell development is impaired in Fyn deficient mice 
 
 In regards to the diminished antibody response observed in Fyn-deficient 
mice, I hypothesized that plasma cell development was impaired in these 
animals. To test this, mice were immunized with NP-KLH and plasma cell 
numbers was determined by flow cytometry 14 days after the immunization. 
Consistent with the defects in antibody production, Fyn-deficient mice showed 
decreased numbers of splenic plasma cells (CD138+B220- cells) (Figure 25a, 
25b). Additionally, being that a large portion of plasma cells generated in 
response to T-dependent antigens is derived from GCs, we examined GC 
formation in these animals. GC B cells, defined as B220+GL7+Fashi were 
enumerated by flow cytometry 14 days following NP-KLH immunization. I 
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observed that Fyn KO animals had significantly low levels of GC B cells 
compared to their littermate controls (Figures 26a, 26b). Furthermore, recent 
literature shows that TFH cells (CXCR5+ PD-1+) provide B cell help via CD40L, 
IL-21 and IL-4 (97-101). I subsequently decided to examine whether the 
decrease in GC B cell numbers was due – or somewhat related – to a decrease 
in the TFH population. Consistent with GC B cells and spleen plasma cells, TFH 
numbers were significantly reduced in Fyn-deficient mice (Figures 26c, 26d). 
Subsequently, these results support the hypothesis that Fyn kinase is involved in 
humoral immunity, affecting TFH, GC B cell and the plasma cell population.  
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Figure 21 
Fyn KO mice have significantly low basal levels of IgG1 and IgG2a. Sera 
were collected from naive Fyn KO mice as well as their littermate controls (WT) 
(n = 8). Circulating antibody titers were measured for IgM (a), IgG1 (b), IgG2a (c) 
and IgG2b (d). No detectable levels of IgG3 or IgE were measured. Data shown 
are mean ± SE of 3 independent experiments performed in triplicate. *p<0.05; 
**p<0.001; ***p<0.0001 based on Student’s t test on Fyn WT and Fyn KO. 
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Figure 22 
Fyn KO animals have impaired antibody titers upon T-dependent 
immunization. WT and Fyn KO mice were immunized intraperitoneally (i.p.) with 
10 µg of NP-KLH + 4 mg of Alum (n = 8-12). NP- specific antibody titers were 
assessed every week for up to 28 days: IgM (a), IgG1 (b), IgG2a (c) and IgG2b 
(d). No detectable levels of NP-specific IgG3 or IgE were measured. Data shown 
are mean ± SE of 3 independent experiments. *p<0.05; **p<0.001; ***p<0.0001 
based on Student’s t test on Fyn WT and Fyn KO. 
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Figure 23 
Immunization strategy.  
WT and Fyn KO mice were immunized intraperitoneally (i.p.) with 10 µg of NP-
KLH + 4 mg of Alum. The first group of mice was monitored for 14 days to mirror 
the primary immunization protocol, during which NP- specific antibody titers were 
assessed at days 7 and 14. The second group of mice was immunized and 
monitored for a longer period of time as indicated on the figure. In addition to the 
primary immunization, these mice received a second inoculation of NP-KLH at 
day 42 (Boost) and were monitored for 5 days following the boost injection. The 
boost injection corresponds to the second encounter of the animal with the 
antigen stimulating the immunological memory of the mouse. 
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Figure 24 
Fyn KO mice have normal spleen size after immunization.  
WT and Fyn KO mice were immunized intraperitoneally (i.p.) with 10 µg of NP-
KLH + 4 mg of Alum and their spleens were extracted 14 days after the 
inoculation of the antigen. (a) Representative images of spleens from WT and 
Fyn KO animals. (b) Graph representing spleen weight. Data shown are mean ± 
SE of 3 spleens. 
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Figure 25 
Fyn deficient mice have low splenic plasma cells upon immunization. WT 
and Fyn KO mice were immunized intra- peritoneally (i.p.) with 10 µg of NP-KLH 
+ 4 mg of Alum (n = 8-12) and spleen plasma cells percentage was assessed 14 
days post immunization (a, b). Data shown are mean ± SE of 3 independent 
experiments. *p<0.05; **p<0.001; ***p<0.0001 based on Student’s t test on Fyn 
WT and Fyn KO. 
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Figure 26 
Fyn deficient mice have low GC B cells and low TFH upon immunization. WT 
and Fyn KO mice were immunized intra- peritoneally (i.p.) with 10 µg of NP-KLH 
+ 4 mg of Alum (n = 8-12). Later, GC B cells (a, b) and TFH (c, d) percentage 
were assessed 14 days post immunization. Data shown are mean ± SE of 3 
independent experiments. *p<0.05; **p<0.001; ***p<0.0001 based on Student’s t 
test on Fyn WT and Fyn KO. 
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Fyn kinase is required for B cell antibody production 
 T cell-secreted cytokines are required for B cell survival and isotype 
switching (110, 111). For example in mice, IL-4 is necessary to drive isotype 
switching to IgG1 and IgE, while IFNγ induces IgG2a production (112). In 
secondary lymphoid organs, T cells are the main producer of both IL-4 and IFNγ, 
which are required for B cell survival and isotype switching. Graham et al. 
demonstrated that IL-4 secreted by TFH is pivotal for B cell survival (113). 
Additionally, Cannons et al. showed that Fyn-deficient T cells have low levels of 
IL-4 subsequent to α-CD3/α-CD28 stimulation (105). Furthermore, previous 
studies demonstrated that Fyn KO NK cells produce reduced amounts of IFN-γ 
(114). Hence, the obvious question was to know whether the phenotype 
observed in Fyn KO mice (i.e. reduced GC B cells and plasma cells) was due to 
low T cell-secreted IL-4 (due to the absence of Fyn) or if the defect extends to 
the B cell population. In fact, given that cytokines play an important role in the 
humoral response, it is possible that our observations are not only due to low T 
cell-derived IL-4 in Fyn KO T cells but instead to the combination of low T cell-
derived IL-4 added to an impaired IL-4 receptor signaling in B cells. In order to 
determine whether Fyn-deficiency leads to a B-cell intrinsic defect downstream of 
the IL-4 receptor, Fyn KO B cells were isolated and stimulated in vitro with anti-
CD40 and IL-4. Subsequent AID expression as well as IgG1, IgE and IgG2a 
production was measured by ELISA. Intriguingly, we did not observe any 
significant reduction in AID expression in Fyn KO B cells (data not shown). 
Furthermore, Fyn KO B cells produced significantly lower amounts of IgG1 and 
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IgE when stimulated with IL-4 (Figures 27a, 27b). These results demonstrate that, 
at least in vitro, Fyn-deficient B cells have impaired activation. Interestingly, we 
did not observe any significant difference in B cell proliferation when WT and Fyn 
KO B cells were cultured in anti-CD40 and IL-4 (Figure 27c). Taken together and 
consistent with previous reports, our results suggest that the impaired antibody 
production observed in Fyn KO involves both the B and the T cell compartments.  
 
Fyn KO B cells have impaired IL-4R signaling  
 As mentioned earlier, B cell IL-4 receptor plays an important role in B cell 
survival and isotype switching to IgG1 and IgE. The observed low titers of IgG1 in 
Fyn KO mice prompted us to investigate IL-4 receptor signaling in Fyn-deficient B 
cells. We hypothesized that IL-4 receptor signaling is somewhat affected in B 
cells, in addition to the previously reported low T cell-derived IL-4 in the absence 
of Fyn (105). To test this hypothesis, we stimulated WT and Fyn KO naïve B cells 
with 30 ng/ml of IL-4 for a total of 60 minutes distributed in five time points. While 
STAT6 phosphorylation seemed unaffected, we observed that STAT3 and 
STAT5 phosphorylation were significantly impaired upon IL-4 receptor stimulation 
(Figure 28). These intriguing findings suggest that Fyn kinase might have a role 
in the JAK-STAT pathway. We hypothesize that Fyn kinase has a proximal 
position in the signaling cascade and might be part of the JAK-STAT complex 
(Figure 29). In fact, our laboratory recently discovered a previously 
unappreciated role of Fyn kinase in FcεRI-induced STAT5 phosphorylation in 
mast cells (64), where Fyn KO mast cells had significantly impaired STAT5 
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activation. 
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Figure 27 
Fyn deficiency affects B cell antibody production but not B cell 
proliferation. WT and Fyn KO naive B cells were isolated from mice (n = 4; 6-8 
weeks of age) and cultured in anti-CD40 (10µg/ml) and IL-4 (10ng/ml) for 7 days. 
IgG1 (a) and IgE (b) titers were measured at the end of the 7th day of culture. In 
order to assess the role of Fyn kinase in proliferation, naive B cells were purified 
from WT and Fyn KO mice and cultured with either anti-CD40 + IL-4 and the 
proliferation was assessed by Tritium (3H) incorporation assay (c). Data shown 
are mean ± SE of 2-4 independent experiments. *p<0.05; **p<0.001; ***p<0.0001 
based on Student’s t test on Fyn WT and Fyn KO. 
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Figure 28 
Fyn KO B cells have impaired STAT3 and STAT5 activation upon IL-4 
stimulation. WT and Fyn KO naive B cells were isolated from mice and 
stimulated with IL-4 (30ng/ml) at 37ºC for indicated times. Cells were lysed and 
phosphorylated forms of STAT3 (pY705 and pS727), STAT5 (pY694) and STAT6 
(pY641) were assessed by western blot. Non-phosphorylated proteins were used 
as loading controls. Representative image of 3 independent experiments.  
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Figure 29 
Proposed role of Fyn in IL-4R-mediated STAT3 and STAT5 activation 
Cytokine receptor signaling involves JAK and STAT molecules. For example, the 
ligation of IL-4 to its receptor will induce intracellular phosphorylation of JAK1 and 
JAK3, which will then phosphorylate STAT6 molecules. Phospho-STAT6 will 
dimerize and translocate to the nucleus and activate IL-4 responsive genes such 
as CD23 and the MHC-II. 
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CHAPTER 3 – DISCUSSION 
 
The innate immune system is the first line of defense against pathogenic 
infection. In the context of human disease, the adaptive immune system is the 
second and mostly the last crucial arm necessary to clear the infection. 
Intracellular pathogens are principally eradicated through cell-mediated 
cytotoxicity mechanisms while extracellular pathogens are mainly cleared by the 
joint action of neutralizing antibodies and phagocytosis.  Subsequently, elevated 
titers of circulating antigen-specific antibodies will promote rapid and efficient 
protection against forthcoming pathogenic infection.  
The immune system produces 5 immunoglobulin isotypes ranging from 
IgM, IgD, IgG, IgE to IgA. IgG isotypes are the most abundant circulating 
antibodies. They are divided in different sub-classes (IgG1, IgG2a, IgG2b and 
IgG3) and these sub-classes bind to specific IgG receptor family members 
(FcγRI, FcγRIII and FcγRIV are the activating receptors while FcγRIIB is the 
inhibitory). In fact, recent studies conducted in mice show that antigen-specific 
IgG1 preferentially binds to the inhibitory IgG receptor FcγRIIB with the highest 
affinity (115). The ligation of IgG1 to FcγRIIB will lead to increased phosphatase 
mobilization through ITIM activation, resulting in an increase of the activation 
threshold. Furthermore, the same study provided the evidence that IgG2a binds 
with moderate and high affinity to the activating IgG receptors FcγRIII and 
FcγRIV respectively. Therefore, IgG2a and IgG2b will be two sub-classes 
capable of eliciting cell activation upon receptor ligation. In terms of physiological 
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relevance in mice, high titers of antigen-specific IgG1 will likely result into a 
“failure” of the immune system to activate the defense mechanism during 
infection while low titers might predict high susceptibility to infection. Here we 
show that Fyn KO mice do not only have significantly low levels of basal IgG1 
and IgG2a (Figure 21) but in addition, have low antigen-specific IgG2a and 
delayed IgG1 kinetics when compared to their littermate controls (Figure 22). 
Intriguingly enough is the fact that Fyn kinase deficiency specifically affects some 
subclasses and not others, suggesting selective regulatory pathways in antibody 
production. 
 In the context of T-dependent immunization, antibody production is 
dependent on GC B cells and TFH. In fact, TFH-derived IL-4 is not only necessary 
to drive and maintain B cell survival but is also important to induce isotype switch 
to IgE and IgG1. While low levels of TFH-derived IL-4 result in decreased B 
(plasma) cell population, nothing is known about the selective pattern of Fyn 
deficiency to affect only IgG1 and IgG2a but not the other immunoglobulin 
subclasses. One possible explanation is that Fyn kinase either recruits or 
activates key factors required for the transcription and/or the translation of the γ1, 
γ2a DNA loci or their corresponding mRNA respectively. 
 Furthermore, in vivo, antibody production is an ensemble of complex 
mechanisms involving different cell types (such as DCs, T cells and B cells) and 
occurring in in different anatomical compartments (spleen and lymph node, just 
to mention these). Therefore, it is challenging to assess the relative contribution 
of each cell type (and biological compartment) as a part of a system. As 
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mentioned earlier, Fyn-deficient T cells secrete less IL-4 after stimulation. We 
ought to assess the contribution of Fyn in B cell IL-4Rα signaling by measuring 
cell proliferation and antibody production. We observed an in vitro correlate to 
our in vivo data, where in vitro stimulation of Fyn KO B cells with anti-CD40 + IL-
4 resulted in significantly low levels IgG1 and IgE compared to the control B cells. 
Additionally, biochemistry studies show that Fyn KO B cells have decreased 
STAT3 and STAT5 activation upon IL-4 receptor ligation (Figure 28). We did not 
observe significant changes in B cell proliferation when the cells were cultured 
with IL-4, consistent with our in vivo observation of low titers of IgG2a.  
 Activation-induced cytidin deaminase (AID) is a key enzyme in Isotype 
switching, class switch recombination and affinity maturation. These processes 
are required for the generation of a variety of adequate subclasses of antibodies. 
Our unpublished observations do not support the hypothesis that Fyn kinase 
deficiency affects AID expression levels. In fact, we noticed that Fyn KO B cells 
had comparable levels of AID enzyme after two days of stimulation with anti-
CD40 + IL-4. 
 Overall, our findings suggest that Fyn kinase plays a key role in antibody 
production, selectively regulating the amount of IgG1 and IgG2a, not only in 
steady state conditions but also in the context of immunization, at least in a 
mouse model. However, specific mechanisms by which this new regulatory 
pathway operates need to be elucidated. Taken together, we report here a 
previously under-appreciated function of Fyn kinase in immunoglobulin subclass 
production, with the hope that these findings will at a certain point contribute to 
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the understanding of human IgG-related disorders, given that human IgG1 and 
IgG3 are very similar to mouse IgG2a and IgG2b respectively. 
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CONCLUDING REMARKS  
 
 Src family tyrosine kinases have pivotal regulatory roles in the immune 
response, affecting both the innate and the adaptive immune system. Our study, 
solely focused on the study of Fyn and Lyn elucidates previously unreported 
function of these two kinases in the regulation of IgG-associated mechanisms. 
What we found have considerable implications in the understanding of IgG-
related diseases. For example, we show that Lyn could now be a potential target 
for the treatment of anaphylaxis. Furthermore, we have been able to demonstrate 
that mast cells can be activated by antigen-specific IgG molecules via Fcγ 
receptor ligation, implying that targeting the IgE and FcεRI pathway should not be 
the only way to alleviate symptoms associated with allergic asthma (where mast 
cells have the central role). Therefore, we suggest considering a therapy that 
would target both the IgG and the IgE pathways, while staying specific to mast 
cells. 
 In addition to reducing the amount of mediator release upon receptor 
stimulation, we also found that Fyn kinase deficiency downregulated IgG1 and 
IgG2a levels in naïve mice. After immunizing these mice, we noticed that Fyn KO 
mice had significantly low titers of antigen-specific IgG2a. As mentioned earlier, 
this IgG subclass is a very potent neutralizing antibody responsible for pathogen 
clearance through ADCC and phagocytosis. Consequently, higher titers of 
antigen-specific IgG2a represent a good baseline insuring rapid protection. 
Understanding the regulatory roles of Fyn kinase in the production of mouse 
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IgG2a is essential for further studies in human subjects. In fact, mouse IgG2a is 
highly similar to human IgG1 for their abilities to fix complement molecules and 
bind protein antigens. IgG1 is the most abundant circulating immunoglobulin 
subclass and is the most suitable for therapeutic use against pathogens and 
cancer cells. 
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